SCHEDULE: BlackRock Reports 6.6% Stake in Viatris Inc.

BlackRock, Inc. has disclosed a 6.6% beneficial ownership stake in Viatris Inc.'s common stock, holding 76,382,158 shares as a passive investor.

Summary

• BlackRock, Inc. reported beneficial ownership of 76,382,158 shares of Viatris Inc. common stock.
• This represents 6.6% of the total class of securities.
• BlackRock holds sole voting power over 71,733,857 shares and sole dispositive power over 76,382,158 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Viatris Inc.
• Various BlackRock business units, including BlackRock Life Limited and BlackRock Fund Advisors, contribute to this aggregate ownership.

Sentiment

Score: 5

Explanation: A Schedule 13G filing is a routine disclosure of beneficial ownership by a passive institutional investor and typically does not carry inherent positive or negative sentiment regarding the issuer's performance or prospects. It simply reports a factual ownership stake.

Future Outlook

This filing is a disclosure of current beneficial ownership and does not contain any forward-looking statements or guidance regarding Viatris Inc.'s future performance or BlackRock's future investment intentions beyond the passive nature of the holding.

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

BlackRock, as one of the world's largest asset managers, routinely discloses significant passive stakes in publicly traded companies like Viatris Inc., a global pharmaceutical company. Such filings reflect institutional investment strategies rather than specific operational or strategic shifts within the issuer's industry.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's passive stake in Viatris Inc.
• Investment Community: Confirms BlackRock's continued passive investment in Viatris Inc.

Key Dates

Keywords

Viatris Inc., BlackRock Inc., SEC Filing, Schedule 13G, Common Stock, Beneficial Ownership, Institutional Investor, Pharmaceuticals, Healthcare